Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer

Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer

Germ cell tumors are the most common malignant tumors in male young adults. Platinum-based chemotherapy has dramatically improved the outcome of metastatic germ cell tumor patients and overall cure rates now exceed 80%. The choice of medical treatment can be guided by the prognosis estimation which...

Full description

Bibliographic Details
Main Authors: Sara Bleve, Maria Concetta Cursano, Chiara Casadei, Giuseppe Schepisi, Cecilia Menna, Milena Urbini, Caterina Gianni, Silvia De Padova, Alessia Filograna, Valentina Gallà, Giovanni Rosti, Domenico Barone, Michal Chovanec, Michal Mego, Ugo De Giorgi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
germ cell tumors
inflammation markers
immunity
chemotherapy
testicular cancer (GCT)
prognostic factors
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.910087/full

Similar Items

Similar Items